Beneficial Effects of Angiotensin II Receptor Blockers on Mortality in Patients with COVID-19: A Retrospective Study from 2019 to 2020 in China

ConclusionsARB administration was significantly associated with a lower risk of all-cause mortality in patients with COVID-19 and CVDs.Trial registrationClinicalTrials.gov NCT05615792.https://www.clinicaltrials.gov/ct2/show/NCT05615792
Source: Cardiovascular Drugs and Therapy - Category: Cardiology Source Type: research